2 persons holding a white box with QuickSTAT written on it

In Part 2, Mike Sweeney, QuickSTAT's Global Head of Strategy for CGT and DTP products, offers specific supply chain design ideas and tactics to establish processes and overcome potential logistics roadblocks. He breaks down extraordinary case studies, and gives his views on what’s next - particularly around regulation.

We continue our conversation with Mike Sweeney, QuickSTAT's Global Head of Strategy for CGT and DTP products, on how to set up robust direct-to-patient and direct-from-patient clinical trial supply chains.

In part one, Mike outlined how sensitive, precise, and flexible one must be in handling and transporting these CGTs that hold such incredible potential for improving if not saving lives. Mike also explained many of the challenges, the strict timing and deadlines, maintaining the required temperature throughout transport to name a few to ensure product integrity and patient safety.

In part two, Mike offers specific system design ideas and tactics to establish processes and overcome inevitable roadblocks. He breaks down extraordinary case studies and gives his views on what's next, particularly around regulation.

A woman medical worker with a mask and full protective equipment

Part 2

Direct to and from patient clinical trial

00:00
00:00

If you haven’t listened to Part 1 you’ll find it here or wherever you get your podcasts.